Cross‐Reactivity of SARS ‐ CoV ‐2 Antibodies With Typhoid Flagellar‐H Protein
Tropical Medicine & International Health · 2025
DOI: 10.1111/tmi.70027 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tropical Medicine & International Health, 2025. Verfasst von Aneela Pasha und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Salmonella typhi, Typhoid Fever. Die Arbeit nennt 33 Literaturangaben.
Abstract (Originalsprache)
Background
Antigen cross‐reactivity in infections may induce heterologous immunity, leading to immunological protection against widely divergent organisms. We hypothesised that this may be a factor in the varying intensity of COVID‐19 infection globally.
Methods
During the COVID‐19 pandemic, we tested 46 symptomatic patients for both COVID‐19 antibodies and the Typhidot test. The kappa statistic in STATA 16.0 was used to analyse agreement between the two tests. Python‐based k‐mer analysis was used to identify overlapping fragments between SARS‐CoV‐2 and Salmonella typhi proteins. PEP‐Fold3, TM‐align and RasMol software were used to evaluate the 3D‐structural changes. World COVID‐19 and Typhoid mortality and infection statistics were obtained from published data. Line graphs were used to assess correlations between Typhoid cases and COVID‐19 mortality.
Results
There was a high degree of agreement between Typhidot and COVID‐19 antibody tests (Cohen's kappa = 0.43, p = 0.0016). A 5‐amino‐acid peptide, NGVEG, located in the receptor binding motif (RBM) of the SARS‐CoV‐2 Spike protein matched with the Typhoid flagellar‐H protein on k‐mer analysis. SARS‐CoV‐2 Delta (B.1.617.2) variant 3D structure displayed marked changes that may have altered this cross‐reactivity. COVID‐19 mortality between Pre‐Delta (2020) and Post‐Delta (2021) periods showed a negative correlation in Typhoid endemic regions and a reverse trend in non‐endemic regions.
Conclusion
Cross‐reactivity of Typhoid flagellar‐H protein antibodies with SARS‐CoV‐2, mediated by a peptide in the RBM, may have provided partial heterologous immunity to COVID‐19 in Typhoid endemic regions and this was eliminated by the Delta variant.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan.
- ImmunoCure - Center for Inflammatory Diseases, Karachi, Pakistan.
ORCID-Profile: Aneela Pasha, Mohammad Saeed
Zitieren
APA
Pasha, A., & Saeed, M. (2025). Cross‐Reactivity of SARS ‐ CoV ‐2 Antibodies With Typhoid Flagellar‐H Protein. Tropical Medicine & International Health. https://doi.org/10.1111/tmi.70027
Vancouver
Pasha A, Saeed M. Cross‐Reactivity of SARS ‐ CoV ‐2 Antibodies With Typhoid Flagellar‐H Protein. Tropical Medicine & International Health. 2025. doi:10.1111/tmi.70027
BibTeX
@article{Pasha2025,
author = {Pasha, Aneela and Saeed, Mohammad},
title = {Cross‐Reactivity of SARS ‐ CoV ‐2 Antibodies With Typhoid Flagellar‐H Protein},
journal = {Tropical Medicine & International Health},
year = {2025},
doi = {10.1111/tmi.70027}
}
EUVIMED